(NASDAQ: TOI) Oncology Institute's forecast annual revenue growth rate of 16.56% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.91%.
Oncology Institute's revenue in 2025 is $424,376,000.On average, 4 Wall Street analysts forecast TOI's revenue for 2025 to be $44,771,017,487, with the lowest TOI revenue forecast at $43,260,915,500, and the highest TOI revenue forecast at $46,665,424,067. On average, 4 Wall Street analysts forecast TOI's revenue for 2026 to be $53,986,847,323, with the lowest TOI revenue forecast at $51,397,700,325, and the highest TOI revenue forecast at $57,180,035,116.
In 2027, TOI is forecast to generate $62,953,954,478 in revenue, with the lowest revenue forecast at $61,083,859,138 and the highest revenue forecast at $65,446,791,566.